CAMBRIDGE, Mass., June 23 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals
Incorporated (Nasdaq: VRTX) will webcast its corporate presentation at the
Bear Stearns Boston Biotech Confab. The presentation and discussion will be
delivered by Ian Smith, Vertex's Senior Vice President and Chief Financial
Officer and John Alam, M.D., Vertex's Senior Vice President of Drug Evaluation
and Approval on Tuesday, June 28, 2005 at 8:45 a.m. EDT.
The presentation and discussion will be webcast live and may be accessed
by visiting the Vertex website at http://www.vrtx.com. A replay of the
webcast will also be available on the Company's website until July 12, 2005.
To access the webcast, go to Vertex's website and select 'Bear Stearns Boston
Biotech Conference.' To ensure a timely connection to the webcast, it is
recommended that users register at least 15 minutes prior to the scheduled
webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is principally focused on viral
diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes
the HIV protease inhibitor, Lexiva(R), with GlaxoSmithKline.
Lexiva(R) is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
Company News On-Call:
http://www.prnewswire.com/comp/938395.html
CONTACT:
Lora Pike, Manager of Investor Relations,
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
